Literature DB >> 2026342

Histological and immunohistochemical study of the gall bladder lesion in primary sclerosing cholangitis.

G P Jeffrey1, W D Reed, S Carrello, K B Shilkin.   

Abstract

The histological features and type of mononuclear cell infiltrate in gall bladders from six patients with primary sclerosing cholangitis were studied using routine staining techniques and immunohistochemistry. Control studies were performed using the gall bladders from six patients (age and sex matched) with chronic cholecystitis and four with primary biliary cirrhosis. A range of histological abnormalities was present in gall bladders from patients with primary sclerosing cholangitis including a mild to moderate degree of epithelial hyperplasia, pseudogland formation, and mononuclear cell infiltrate of the epithelium; moderate to severe chronic inflammatory cell infiltrate and fibrosis affecting the superficial and deep layers of the gall bladder wall; and minimal smooth muscle hypertrophy. These abnormalities were non-specific and were also present in gall bladders from patients with chronic cholecystitis and primary biliary cirrhosis. Vasculitis and granulomas were not present in the patients with primary sclerosing cholangitis. Immunohistochemistry showed that the superficial and deep mononuclear cell infiltrate in primary sclerosing cholangitis gall bladders was composed predominantly of lymphocytes, in contrast to chronic cholecystitis where macrophages were found in similar or greater numbers. Moreover, T lymphocytes (activated and resting) were present throughout the lymphocytic infiltrate and were apposed to the base and interdigitated between the biliary epithelial cells in significantly greater numbers than in chronic cholecystitis gall bladders. B lymphocytes were present only in lymphoid follicles. Comparative studies using liver biopsy specimens from three of the primary sclerosing cholangitis patients showed a similar T lymphocyte portal tract infiltrate. We conclude that a number of non-specific chronic inflammatory histological abnormalities were present in primary sclerosing cholangitis gall bladders. Immunohistochemistry found other features that were present in this disease - a predominantly lymphocytic mononuclear cell infiltrate of the superficial and deep layers of the gall bladder wall and the presence of T lymphocytes that infiltrated the biliary epithelial cells. These findings support the hypothesis that aberrant cell mediated immune mechanisms may play a role in the pathogenesis of both the intrahepatic and extrahepatic lesions in primary sclerosing cholangitis.

Entities:  

Mesh:

Year:  1991        PMID: 2026342      PMCID: PMC1379084          DOI: 10.1136/gut.32.4.424

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  23 in total

1.  Chronic granulomatous cholecystitis and chronic fibrosing choledochitis associated with chronic ulcerative cofitis. A case report.

Authors:  M B GOLDGRABER; J B KIRSNER
Journal:  Gastroenterology       Date:  1960-05       Impact factor: 22.682

2.  Primary sclerosing cholangitis; review and report of six cases.

Authors:  S I SCHWARTZ; W A DALE
Journal:  AMA Arch Surg       Date:  1958-09

3.  Primary sclerosing cholangitis: clinical and immunopathological review of 21 cases.

Authors:  G P Jeffrey; W D Reed; B H Laurence; K B Shilkin
Journal:  J Gastroenterol Hepatol       Date:  1990 Mar-Apr       Impact factor: 4.029

4.  Peripheral blood and portal tract lymphocyte populations in primary sclerosing cholangitis.

Authors:  J A Snook; R W Chapman; G K Sachdev; A Heryet; P M Kelly; K A Fleming; D P Jewell
Journal:  J Hepatol       Date:  1989-07       Impact factor: 25.083

5.  Impaired delayed hypersensitivity in primary biliary cirrhosis.

Authors:  S Sherlock; R A Fox; D G James; P J Scheuer; O Sharma
Journal:  Lancet       Date:  1969-05-10       Impact factor: 79.321

6.  Bile duct cysts secondary to liver infarcts: report of a case and experimental production by small vessel hepatic artery occlusion.

Authors:  J L Doppman; N R Dunnick; M Girton; A S Fauci; M A Popovsky
Journal:  Radiology       Date:  1979-01       Impact factor: 11.105

7.  A coded histologic study of hepatic graft-versus-host disease after human bone marrow transplantation.

Authors:  H M Shulman; P Sharma; D Amos; L F Fenster; G B McDonald
Journal:  Hepatology       Date:  1988 May-Jun       Impact factor: 17.425

8.  Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology.

Authors:  R W Chapman; B A Arborgh; J M Rhodes; J A Summerfield; R Dick; P J Scheuer; S Sherlock
Journal:  Gut       Date:  1980-10       Impact factor: 23.059

9.  Leukocyte migration inhibition in response to biliary antigens in primary biliary cirrhosis, sclerosing cholangitis, and other chronic liver diseases.

Authors:  I G McFarlane; B M Wojcicka; D C Tsantoulas; B C Portmann; A L Eddleston; R Williams
Journal:  Gastroenterology       Date:  1979-06       Impact factor: 22.682

10.  The in vivo metabolism of C3 in hepatobiliary disease associated with ulcerative colitis.

Authors:  L Brinch; P Teisberg; E Schrumpf; I Akesson
Journal:  Scand J Gastroenterol       Date:  1982-06       Impact factor: 2.423

View more
  4 in total

Review 1.  Primary sclerosing cholangitis: updates in diagnosis and therapy.

Authors:  Piero Portincasa; Michele Vacca; Antonio Moschetta; Michele Petruzzelli; Giuseppe Palasciano; Karel J van Erpecum; Gerard P van Berge-Henegouwen
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

Review 2.  Primary sclerosing cholangitis--approach to diagnosis.

Authors:  Ian L Steele; Cynthia Levy; Keith D Lindor
Journal:  MedGenMed       Date:  2007-04-25

3.  The value of thioredoxin family proteins and proliferation markers in dysplastic and malignant gallbladders in patients with primary sclerosing cholangitis.

Authors:  Karouk Said; Hans Glaumann; Mikael Björnstedt; Annika Bergquist
Journal:  Dig Dis Sci       Date:  2012-02-28       Impact factor: 3.199

Review 4.  Mast Cells in Immune-Mediated Cholangitis and Cholangiocarcinoma.

Authors:  Marisol I González; Danielle T Vannan; Bertus Eksteen; Irán Flores-Sotelo; José Luis Reyes
Journal:  Cells       Date:  2022-01-22       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.